Abstract:After uptake by U87 MG and A375 cancer cells, cobaltabisdicarbollide [COSAN]- distributes between membrane and nucleus and presents no relevant cytotoxicity against both cell lines even for long incubation times. The cytotoxicity of Na[COSAN] was also tested towards one normal cell line, the V79 fibroblasts, in order to ascertain the noncytotoxic profile of the compound. As the cell's nucleus contains DNA, the interaction between [COSAN]- and double-stranded calf thymus DNA (CT-dsDNA) has been investigated. There is a strong interaction between both molecules forming a nanohybrid CT-dsDNA-[COSAN] biomaterial, which was fully characterized. Moreover, Na[COSAN] shows characteristic redox peaks ascribed to the oxidation/reduction of Co3+/2+ at a formal potential of -1.444 V and it can be accumulated at a surface-immobilized DNA layer of glassy carbon electrodes. The equilibrium surface-binding constants (Kox /Kred ), which confirm that [COSAN]- interacts with DNA by an intercalative or electrostatic mode, depending on the ionic strength of the solution, were estimated. In addition, high binding affinity of Na[COSAN] to proteins was observed by 11 B{1 H} NMR and confirmed in vivo. Finally, biodistribution studies of [COSAN]- in normal mice were run. After administration, Na[COSAN] was distributed into many organs but mainly accumulated in the reticuloendothelial system (RES), including liver and spleen. After 1 h, the formation of aggregates by plasma protein interaction plays a role in the biodistribution profile; the aggregates accumulate mostly in the lungs. Na[COSAN], which displays low toxicity and high uptake by relevant cancer cells accumulating boron within the nucleus, could act as a suitable compound for further developments as boron neutron capture therapy (BNCT) agents.

Metallacarboranes in Medicinal Chemistry: Current Advances and Future Perspectives

Carboranes in drug discovery, chemical biology and molecular imaging

Metallacarboranes on the Road to Anticancer Therapies: Cellular Uptake, DNA Interaction, and Biological Evaluation of Cobaltabisdicarbollide [COSAN]

Quantum Chemical and Biological Insights into Redox Activity of Metallacarborane Complexes in Cancer Cells

Cobaltabis(dicarbollide) Interaction with DNA Resolved at the Atomic Scale

Oxidation states in metallocenes: A key mechanistic component in cancer alleviation

Bimetallic Cooperative Catalysis for Decarbonylative Heteroarylation of Carboxylic Acids Via C‐O/C‐H Coupling

Coordinative Compounds Based on Unsaturated Carboxylate with Versatile Biological Applications

Unraveling the Correlation between Biological Effects and Halogen Substituents in Cobalt bis(dicarbollide)

Advances in the Synthesis of Biscarboranes

Charge-Compensated Metallacarborane Building Blocks for Conjugation with Peptides

Potential of organometallic complexes in medicinal chemistry

Dicarbanion Compounds: the Bridge Between Organometallic Reagents and Mononuclear Heterocycles

Emerging metallenes: synthesis strategies, biological effects and biomedical applications

Synthesis of Bis(Carboranyl)amides 1,1'-μ-(CH2NH(O)C(CH2)n-1,2-C2B10H11)2 (n = 0, 1) and Attempt of Synthesis of Gadolinium Bis(Dicarbollide)

Dysprosiacarboranes: A New Type of Organometallic Single-Molecule Magnets

Biological Activity of Late Transition Metal‐Based Compounds: From Computational and Theoretical Studies to Laboratory Exploration and Beyond

Boron Chemistry for Medical Applications

Transition Metal Complexes Based on Carboranyl Ligands Containing N, P, and S Donors: Synthesis, Reactivity and Applications

Anticancer Metallocenes and Metal Complexes of Transition Elements from Groups 4 to 7

Strategies to address key challenges of metallacycle/metallacage-based supramolecular coordination complexes in biomedical applications